Spots Global Cancer Trial Database for recombinant human erythropoietin (rhuepo)
Every month we try and update this database with for recombinant human erythropoietin (rhuepo) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy | NCT00120679 | Non-Small Cell ... Anemia | darbepoetin alf... recombinant hum... | 18 Years - | Amgen | |
| Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy | NCT00121030 | Gynecological M... Genital Neoplas... Anemia | darbepoetin alf... recombinant hum... | 18 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
